ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TeleVox Launches AI-Enabled Omnichannel Conversational Virtual Assistant for Healthcare Providers

CHICAGO, April 17, 2023 (GLOBE NEWSWIRE) -- TeleVox, an industry-leading provider of omnichannel digital patient technology, unveiled its latest innovation at the HIMSS Conference (April 17-19). Iris™ is the newest addition to the company's end-to-end digital patient engagement platform, HouseCalls Pro. Iris is a powerful AI-driven virtual agent accessible via web, voice, and SMS interactions and embedded into HouseCalls Pro patient engagement workflows. Utilizing Microsoft Azure OpenAI Service with its large-scale, generative AI models and other chat technology, Iris provides patients with quick access to information and easy completion of common tasks, improving patient access and self-service. Iris enables call deflection and reduces operational burden and costs for health systems. When necessary, Iris can seamlessly connect patients with a live agent chat for timely and accurate assistance.

Iris sets a new standard for conversational virtual assistants by surpassing current basic chatbots that utilize limited content, require extensive training, and lack an EHR-integrated, omnichannel experience. With its advanced AI capabilities and access to a vast range of published content, Iris can provide immediate responses to a wide range of patient queries, making it the most comprehensive solution available. By integrating voice, web chat, and SMS capabilities into a single omnichannel experience, healthcare providers can offer self-service options to patients for a variety of common activities, reducing the burden on staff and increasing patient acquisition. Iris is highly flexible and can be easily integrated with existing EHRs or deployed as a standalone solution, ensuring a seamless patient engagement experience.

"As a leader in patient engagement technology for over three decades, TeleVox has continuously strived to enhance the patient experience and care through innovation," said Vik Krishnan, President of TeleVox. "Iris, a new generation of AI-enabled patient-provider communication, marks a significant milestone in the evolution of patient engagement technology and enables health systems to deliver the self-service experience that consumers expect today.”

Iris integrates a full range of communication technologies, including web chat, conversational SMS messaging, and automated telephone responses, providing patients with the flexibility to engage with healthcare providers on their own terms. Unlike other chatbot solutions that can leave patients feeling frustrated by dead-end conversations, Iris will seamlessly connect patients with a live representative should they require further assistance. Moreover, healthcare organizations can easily incorporate their website and other content into the automated system, providing patients with customized and easy-to-understand "FAQ" content in natural language. By leveraging Iris's advanced AI and chat technologies, patients will receive real-time responses to their questions, reducing response times and increasing patient satisfaction.

“Healthcare providers face immense challenges in managing the patient care journey, from providing high-quality care to increasing visit volumes and revenue streams while simultaneously reducing staff workload,” said Kamal Anand, Chief Product Officer, TeleVox. “Iris, with its use of Azure OpenAI Service and chat technologies, is the solution that healthcare organizations need to meet these challenges.”

“Microsoft’s advancements in AI are grounded in our company’s mission to help every person and organization on the planet to achieve more,” said Brian Willson, Vice President, West & Midwest region, Microsoft. “TeleVox is embracing this mission by improving patient experiences and mitigating staff burnout in healthcare, using Microsoft Azure OpenAI Service to develop innovative solutions that can make a real difference in people's lives."

KLAS, a leading analyst in the patient engagement space, provided additional comments on the announcement. “Technology advances through AI and other tools have created opportunity to significantly improve patient engagement,” said Adam Cherrington, Vice President Digital Health at KLAS. “It’s critical that healthcare organizations identify and leverage platforms that significantly enhance the patient experience while addressing serious operational shortfalls.”

About TeleVox
TeleVox is a leading provider of omnichannel digital patient engagement technology. Our solutions are used by more than 10,000 healthcare organizations—from hospitals and health systems to community health centers—to engage, educate, and empower patients throughout their care journey. Our patient engagement platform integrates with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. And our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through customized communication. All of these exchanges are possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue while making the healthcare communication process easier for everyone. TeleVox is a part of West Technology Group, LLC (formerly Intrado Corporation) controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Learn more at www.televox.com.

Contacts:

John O’Hara
Mower
(315) 409-9879

Donald Thompson
TeleVox
(315) 720-3304


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.